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Introduction 
 Tobacco use is a major contributor to overall morbidity and mortality in the 
United States.  Cigarette smoking and exposure to tobacco smoke contribute to 
approximately one in every five deaths annually in the United States (Centers for Disease 
Control and Prevention [CDC], 2013).  The most common causes of smoking-attributable 
death are lung cancer, chronic obstructive pulmonary disease (COPD), and ischemic 
heart disease (United States Department of Health and Human Services [HHS], 2004). 
Tobacco use also leaves a heavy economical burden on the U.S. with approximately $193 
billion in direct medical expenses and lost productivity being attributable to smoking 
each year (CDC, 2013). 
 Over 50% of smokers make a quit attempt each year but most smokers make 
multiple quit attempts before being successful (CDC, 2013).  Counseling and medication 
have been shown to be effective interventions in assisting smokers to make successful 
smoking cessation attempts (Fiore et al., 2008).  Primary care providers play a key role in 
assisting tobacco users in their quit attempts.  The Public Health Service clinical practice 
guideline on Treating Tobacco Use and Dependence gives specific recommendations on 
identifying and assisting tobacco users in the health care setting.  By following guideline 
recommendations, primary care providers can make a considerable impact on their 
patients' abilities to successfully quit smoking.   
 This capstone report presents three manuscripts which focus on tobacco use 
interventions in the primary care setting.  The first manuscript presents a critical analysis 
of the Public Health Service guideline on Treating Tobacco Use and Dependence.  The 
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second manuscript presents a literature review pertaining to interventions that increase 
primary care provider compliance with guideline recommendations.  The literature 
obtained from these first two manuscripts led to a descriptive study, which examined 
the documentation and implementation of specific guideline recommendations in a 
primary care clinic.  The third and final manuscript details this study, and 
presents some practical implications for improving documentation and implementation of 
tobacco use interventions in primary care.   
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Abstract 
 This paper discusses and analyzes the Public Health Service clinical practice 
guideline Treating Tobacco Use and Dependence: 2008 Update.  The guideline provides 
evidence-based recommendations on interventions and treatments for tobacco users in a 
clear and concise manner that can easily be applied by a variety of health care providers.  
This paper will discuss the development process of the guideline, stakeholder 
involvement, editorial independence, and overall presentation and application of the 
guideline.  Comparison of the guideline to the U.S. Preventive Services Task Force 
recommendations and application of a theoretical framework to guideline 
recommendations will also be discussed.   
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Tobacco Use and Dependence Guideline: An Analysis 
 Tobacco use, the leading cause of preventable morbidity and mortality, continues 
to be a significant health issue in the United States (Centers for Disease Control and 
Prevention [CDC], 2013).  Each year approximately 8.6 million people in the United 
States suffer from a smoking-attributable disease and 443,000 of these individuals die 
from smoking or exposure to secondhand smoke (CDC, 2013).  Tobacco use can lead to 
heart disease, cancer, and pulmonary disease as well as exacerbate existing chronic health 
conditions (United States Department of Health and Human Services [HHS], 2004).  
Tobacco use also leaves a heavy economical burden on the U.S. with approximately $193 
billion in direct medical expenses and lost productivity being attributable to smoking 
each year (CDC, 2013).   
 The prevalence of smoking among adults varies by state and region with the 
lowest rate of smoking in Utah at 11.8% and the highest rate in Kentucky with 29% of 
adults reporting current cigarette smoking in 2011 (CDC, 2013).  The overall prevalence 
of adults who use smokeless tobacco products was 4.4% in 2011, with a prevalence of 
6.8% in Kentucky (CDC, 2013).  Kentucky has a high prevalence of tobacco use as it is a 
tobacco-growing state in which the use of tobacco is embedded into the culture (CDC, 
2013). 
 Tobacco use cessation can greatly benefit overall health at any age (CDC, 2011; 
CDC, 2013).  In 2010, nearly 70% of adult smokers reported interest in smoking 
cessation and over 50% of smokers had made at least one quit attempt in the past year 
(CDC, 2011).  However, only 6.2% of smokers surveyed reported a successful smoking 
cessation attempt (CDC, 2011).  These statistics demonstrate many smokers are willing to 
 7 
quit but face many challenges in their attempts at quitting.  In order to increase successful 
quit attempts, health care providers should identify tobacco users and provide assistance 
to those individuals attempting to quit.   
 Clinical practice guidelines can assist providers in delivering evidence-based care 
when intervening with a tobacco user.  In 2008, the Public Health Service published the 
clinical practice guideline Treating Tobacco Use and Dependence: 2008 Update (Fiore et 
al., 2008).  The guideline was originally developed to provide evidence-based 
recommendations on interventions and treatments that health care providers can utilize to 
help tobacco users overcome their dependence on tobacco.  The guideline focuses on 
simple, adaptable approaches to assessment and treatment of tobacco users that can be 
used in a variety of settings by virtually any health care provider.  The guideline was 
updated to include new treatments for tobacco dependence, such as varenicline, that have 
become available since the previous guidelines were published in 1996 and 2000 (Fiore 
et al., 2008).   
Stakeholder Involvement 
 The 2008 updated guideline was sponsored by eight private nonprofit and 
government organizations.  These organizations included the Agency for Healthcare 
Research and Quality (AHRQ), the CDC, the National Cancer Institute (NCI), the 
National Heart, Lung, and Blood Institute (NHLBI), the National Institute on Drug Abuse 
(NIDA), the American Legacy Foundation, the Robert Wood Johnson Foundation, and 
the University of Wisconsin Center for Tobacco Research and Intervention (UW-CTRI).  
The guideline was published by the Public Health Service (PHS) as tobacco use is an 
important health issue to all Americans (Fiore et al., 2008).    
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 The guideline consortium included many of the top organizations involved in 
tobacco use prevention, control, and treatment.  Other organizations that are involved in 
reducing the impact of tobacco use in the United States and could have contributed to 
guideline development include the American Cancer Society (ACS), the American Lung 
Association, and the Association for the Treatment of Tobacco Use and Dependence 
(ATTUD).  Due to the direct link between tobacco use and several types of cancer (HHS, 
2004), the American Cancer Society is often involved in research, events, and policy 
directed at reducing the negative health effects of tobacco use (ACS, n.d.).  Tobacco use 
can also cause and exacerbate chronic lung conditions such as asthma or chronic 
obstructive pulmonary disease (HHS, 2004).  The American Lung Association is very 
active in secondhand smoke exposure and tobacco use prevention, control, and treatment 
(American Lung Association, n.d.).  ATTUD is an organization of providers dedicated to 
promoting evidence-based tobacco use treatment (ATTUD, n.d.).  For future updates of 
the guideline, input from these organizations should be sought to expand the knowledge 
base and expertise involved in guideline development.   
Rigor of Development 
 Evidence was obtained from systematic reviews conducted for the original 
guidelines in 1996 and 2000 as well as an updated systematic review of evidence from 
1999 to 2007.  Prior to the updated systematic review, the guideline panel selected eleven 
topics for updated meta-analysis, including the effectiveness of varenicline.  A literature 
search of eleven electronic databases and published abstracts and bibliographies was 
conducted.  A total of 8,700 articles were screened for the systematic reviews including 
2,700 new articles screened since the 2000 guideline (Fiore et al., 2008). 
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 Literature reviewers screened article abstracts for inclusion and exclusion criteria.  
Articles were included in meta-analysis if they met the following criteria: reported results 
of a randomized controlled trial (RCT) of a tobacco use treatment intervention, provided 
at least 5 months of follow up after the quit date (except for pregnant smokers), were 
published in English in a peer reviewed journal between January 1975 to June 2007, and 
pertained to one of the 11 topics chosen for 2008 guideline meta-analysis.  More than 300 
articles were identified for inclusion in meta-analysis (Fiore et al., 2008). 
 Evidence obtained from the literature search was then reviewed by three 
independent reviewers and coded into evidence tables using the same coding process 
employed by the 2000 guideline.  Articles were reviewed to assess relevancy to the 
treatment characteristic being evaluated.  Selected articles were then reviewed for 
specific screening criteria and for possible confounders in the treatment or control arms.  
Studies that were deemed appropriate by the panel were then analyzed using meta-
analysis. The primary meta-analytic model used was logistic regression using random 
arms modeling.  Logistic regression coefficients obtained from the meta-analysis were 
then converted to odds ratios with 95 percent confidence intervals (CI).  The odds ratios 
were then converted to abstinence percentages with 95 percent confidence intervals.  The 
abstinence percentages represent an estimated long-term abstinence rate obtained under 
the tested treatment (Fiore et al., 2008).   
 Evidence was also graded for quality and strength using a rating scheme.  
Evidence supporting a recommendation was given a grade "A" if multiple, well-designed 
RCTs produced consistent results supporting the recommendation.  A grade of "B" 
indicated that evidence from RCTs supported the recommendation but the evidence was 
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not optimal.  For example few RCTs existed or the trials were inconsistent. 
Recommendations based on consensus or nonrandomized trials were given a grade "C" 
(Fiore et al., 2008).  
 It is important for clinicians to consider possible limitations and bias when 
reviewing any evidence-based recommendations.  There are limitations and areas for 
potential bias with meta-analyses including inclusion and exclusion criteria selected, 
methods of analysis, and heterogeneity of results.  Due to publication bias, meta-analyses 
may not always represent the true sample of all studies undertaken but may be more 
representative of studies with favorable results.   
 Most recommendations were based on numerous well designed studies.  In areas 
such as policy issues or cost-effectiveness in which randomized trials are difficult, the 
strength of the evidence was based on the number, quality, and consistency of studies.  In 
areas in which evidence was weak or inconsistent, the panel declined to make 
recommendations.  The guideline was also validated by 81 external peer reviewers and 
fifteen members of the public (Fiore et al., 2008).  Therefore, clinicians can be confident 
that the guideline recommendations are valid and evidence-based. 
  The guideline does not specify the procedure for updates.  However the 
current version of the guideline is an update to the original guidelines published in 1996 
and 2000.  The 2000 guideline was updated due to new treatments that have become 
available for tobacco dependence (Fiore et al., 2008).  Since the guideline was published 
in 2008 new technologies and treatments, such as the e-cigarette, have emerged which 
may warrant a new update.   
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Clarity and Presentation 
 The guideline highlights ten key recommendations that are listed immediately 
following the abstract of the document.  These recommendations provide an overview of 
the more detailed, specific recommendations provided later in the document.  An 
example of one of the key recommendations is "It is essential that clinicians and health 
care delivery systems consistently identify and document tobacco use status and treat 
every tobacco user seen in a health care setting" (Fiore et al., 2008, p. vi).  For each of the 
recommendations the guideline provides a table with summary of the evidence (odds 
ratio and abstinence rates with 95% CI) and a discussion of clinical practice suggestions 
and future research recommendations.   
 In Chapter 2 of the document an algorithm is provided which details the steps a 
provider should take to identify and treat a tobacco user seen in a health care setting.  
Other key recommendations include providing brief and repeated interventions as 
tobacco cessation typically involves multiple quit attempts.  The guideline also discusses 
the importance of clinically and cost-effective treatment, including counseling and 
medication, in the key recommendations (Fiore et al., 2008).   
 The guideline outlines strategies that clinicians can use based on the patient's 
current tobacco use status and willingness to quit.  For example the guideline provides 
strategies to prevent relapse in former smokers and discusses motivational techniques to 
encourage tobacco users unwilling to quit to consider making a quit attempt.  The 
guideline discusses in depth the available treatment options for tobacco use and 
dependence including medications and counseling.   The guideline also covers systems 
interventions, cost-effectiveness of tobacco use interventions, and special populations 
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such as pregnant smokers (Fiore et al., 2008).  For more detailed information on 
guideline recommendations see Appendix A.   
Application 
 The guideline indicates clinicians are inconsistently delivering tobacco use 
interventions to their patients and cites evidence of a lack of systems support, such as 
training or automated prompting.  The guideline gives recommendations to overcome 
these barriers such as designating a staff member to coordinate tobacco dependence 
treatments.  This individual would ensure that clinicians receive adequate training and 
performance feedback as well as provide sufficient resources to provide the 
recommended treatments to patients (Fiore et al., 2008).  The guideline also recommends 
the promotion of policies that support tobacco dependence services and the use of a 
tobacco user identification system in every clinic.  By dedicating staff members to 
champion tobacco use interventions and employing policies and procedures that identify 
tobacco users and promote tobacco dependence treatments, guideline recommendations 
can more readily be implemented.   
 Another major obstacle to the implementation of tobacco use treatments is the 
financial cost of recommended treatments such as medication.  Insurance coverage of 
tobacco use interventions has drastically improved since the first guideline was published 
in 1996.  However comprehensive coverage is still inconsistent among private insurers 
and state Medicaid programs (Fiore et al., 2008).  The guideline recommends all tobacco 
dependence treatments deemed effective by the evidence presented in the guideline 
should be covered services for all members of health insurance packages.   
 13 
 The tobacco dependence treatments highlighted in the guideline, such as 
counseling and medication, are highly cost-effective relative to other reimbursed 
treatments such as routine mammography or hypertension treatment.  For example the 
estimated cost per life-year saved of nicotine replacement therapy is $3,455 as compared 
to annual cervical cancer screening for women ages 34 to 39 which is $4,100 (Song et al., 
2002; Tengs et al., 1995).  The guideline discusses cost-effectiveness of tobacco 
dependence treatment in terms of cost per quality-adjusted-life-year (QALY) saved, cost 
per quit, health care costs and utilization pre- and post-quit, and return on investment for 
coverage.  For example, costs of tobacco dependence treatment have been estimated to 
range from a few hundred to a few thousand dollars per QALY saved (Fiore et al., 2008). 
Theoretical Framework 
 Clinicians often utilize the principles and features of theoretical frameworks to 
apply guideline recommendations.  The Transtheoretical Model, or stages of change 
model, is often utilized and applied to tobacco cessation intervention and treatment.  The 
Transtheoretical Model was developed by Prochaska and DiClemente and utilizes the 
dimensions of stages of change and processes of change (DiClemente et al., 1991; 
Prochaska & DiClemente, 1983).  Stages of change include Precontemplation, 
Contemplation, Preparation, Action, and Maintenance.  Processes of change include 
activities or events that create successful behavior modification. Examples include 
helping relationships, self reevaluation, and consciousness-raising (DiClemente et al., 
1991).   
 The Transtheoretical Model has been used to help change many health behaviors 
including tobacco use.  The Precontemplation stage of change as it relates to tobacco 
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cessation is typically defined as an individual with no plans to quit within the next six 
months.  Individuals in the Contemplation stage are thinking about quitting tobacco in the 
next six months.  The Preparation stage is defined as individuals planning on quitting in 
the next thirty days.  Action represents individuals that have initiated a quit attempt.  
Individuals move onto the Maintenance phase once they have been quit for a defined 
amount of time, usually six months to one year.  Individuals usually cycle through the 
stages of change.  In other words, most people attempting to quit relapse and may move 
back into the Precontemplation, Contemplation, or Preparation stages (Anczak & Nogler, 
2003; DiClemente et al., 1991; Prochaska & DiClemente, 1983).  
 Anczak and Nogler (2011) describe ways in which primary care providers can 
utilize the Transtheoretical Model to promote smoking cessation in their patients.  For 
patients in the Precontemplation and Contemplation stages, the provider should advise 
the patient to quit and inform the patient on the adverse effects of smoking.  The 
guideline also recommends motivational interviewing for individuals in these stages 
(Fiore et al., 2008).  In the Preparation stage, the provider can begin discussing strategies 
for quitting, such as behavior modification and medication use.  Providers should give 
support, provide positive reinforcement, and schedule frequent visits during the Action 
phase to prevent relapse (Anczak & Nogler, 2011).  Preventing relapse continues to be 
important in the Maintenance phase.  The guideline suggests that clinicians review the 
benefits of quitting, reinforce the patient's success at quitting, and address any problems 
that have arisen from quitting with individuals who have recently quit (Fiore et al., 2008).  
Overall the clinician's role in utilizing the Transtheoretical Model in tobacco cessation is 
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to motivate patients to quit and assist patients that are motivated in successfully quitting 
and maintaining abstinence (Anczak & Nogler, 2011; Fiore et al., 2008).   
Editorial Independence 
 The guideline was developed and funded by the Public Health Service, a U.S. 
governmental agency.  As mentioned previously it was sponsored by eight nonprofit 
private and governmental organizations.  A two-step procedure was followed to evaluate 
potential conflicts of interest among panel members.  Prior to the first panel meeting in 
October 2006, all panel members completed a general screening process in which 
potential conflicts of interest over the last five years were reported in a narrative fashion.  
Prior to the second meeting in 2007 panel members underwent a more detailed disclosure 
process based on the Department of Health and Human Services guidelines for the 
conduct of research.  After the disclosure process, three panel members were excluded 
due to areas of conflict and one panel member voluntarily excluded himself from panel 
deliberations and guideline development.  The guideline provides a summary of all 
disclosures made by panel members (Fiore et al., 2008). 
Recommendation 
 In 2009, The U.S. Preventive Services Task Force (USPSTF) released 
recommendations on counseling and other interventions to prevent tobacco use and 
tobacco-related disease.  The USPSTF reviewed the evidence from the Public Health 
Service guideline and had similar recommendations based on this evidence.  Both 
guidelines recommend the use of a specific method called the 5As when interacting with 
tobacco users.  The USPSTF addresses pregnant tobacco users but does not discuss other 
special populations such as children or light smokers as does the PHS guideline (Fiore et 
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al., 2008; USPSTF, 2009).  Both guidelines agree that counseling with practical guidance 
and social support should be an included component of tobacco cessation interventions.  
The PHS guideline provides detailed recommendations on pharmacotherapy while the 
USPSTF guideline only briefly mentions tobacco cessation medications approved by the 
U.S. Food and Drug Administration (FDA).  Both guidelines agree that a combination of 
counseling and medications are more effective than either intervention performed alone 
(Fiore et al., 2008; USPSTF, 2009). 
 Overall, both guidelines were created to provide recommendations to clinicians 
on effective interventions to prevent tobacco-related disease and promote tobacco 
cessation.  Though either guideline can easily be used to screen and assess tobacco users, 
the PHS guideline is more useful in providing tobacco cessation treatment.  The PHS 
guideline provides more detailed, practical, and specific recommendations on tobacco 
cessation treatments that can easily be utilized by clinicians in practice (Fiore et al., 2008; 
USPSTF, 2009).   
 Nurse practitioners and other providers are highly involved in preventive health 
care services such as tobacco cessation.  It is the ethical and perhaps legal responsibility 
of nurse practitioners to identify their patients that use tobacco and use evidence-based, 
effective strategies to treat tobacco dependence.  It has been suggested that failure to 
address and treat preventable causes of disease using established standards of care, such 
as clinical practice guidelines, can be viewed as a violation of the legal duty providers 
owe to their patients (Torrijos & Glantz, 2006).  Therefore it is critical that providers 
follow evidence-based recommendations for intervening with tobacco users in attempts to 
reduce tobacco-related death and disease.     
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 The PHS guideline can serve as the foundation to providers' interventions with 
tobacco users.  Providers in any health care setting can apply the guideline to their 
patients who abuse tobacco and motivate and assist their patients to quit. By utilizing 
clinical practice guidelines to guide tobacco cessation interventions, nurse practitioners 
can have a positive and lasting effect on the health of their patients as well as the 
population at large.   
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Abstract 
 
 Tobacco use is a major contributor to overall morbidity and mortality in the 
United States.  Smoking cessation is the only proven method to reduce the harmful 
personal health effects associated with tobacco use.  Primary care clinicians have a 
responsibility to intervene with tobacco users and increase successful cessation attempts.  
Evidence-based strategies are available to assist providers in treating tobacco use.  
However, many providers do not address tobacco use adequately.  The Public Health 
Service released clinical practice guidelines in 1996 and 2000 with an update in 2008 on 
tobacco use and dependence.  This paper reviews the current literature on strategies to 
increase provider compliance with tobacco use guideline implementation, specifically use 
of the 5A method.  Sixteen studies from a meta-analysis and a literature search were 
selected for review.  The studies discussed educational interventions, financial incentives, 
provider feedback, vital sign stamps, and multi-component interventions to increase 
guideline compliance.  Overall, multi-component interventions were found to be most 
effective in improving provider performance of guideline recommendations.  Further 
investigation may be warranted on specific educational components, frequency and 
method of feedback, and interventions to increase follow-up. 
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Improving Primary Care Provider Compliance with  
Tobacco Use Guidelines: A Review of Evidence-based Interventions 
 
 Tobacco use is the leading cause of preventable mortality and morbidity in the 
United States (Centers for Disease Control and Prevention [CDC], 2009).  Tobacco use 
and dependence is a chronic disease that often requires multiple interventions and 
attempts to quit (Fiore at el., 2008)  Quitting smoking has both immediate and long term 
health benefits and is the only proven method to reduce the pathologic effects of cigarette 
smoke on cardiovascular and pulmonary health (United States Department of Health and 
Human Services [HHS], 2004; HHS, 2010).  Reduction in the number of cigarettes 
smoked daily has not been shown to significantly benefit health.  Complete smoking 
cessation is the only proven method in reducing the harmful effects associated with 
tobacco use (HHS, 2010).   
 Smoking cessation is an extremely difficult behavioral health change for 
individuals partly due to the addictive nature of nicotine (CDC, 2013).  In 2010 sixty-
eight percent of adult smokers surveyed said they wanted to quit smoking but only six 
percent of smokers had successfully quit in the past year (CDC, 2011).  To optimize 
chances for success with smoking cessation smokers need support and guidance from 
trained health professionals who provide evidence-based treatment options. 
 Evidence-based practice guidelines exist to direct clinicians in providing effective 
tobacco use treatment options.  In 2008, the Public Health Service published an update to 
its clinical practice guideline for treating tobacco use (Fiore et al, 2008).  The overall goal 
of the guideline is to encourage clinicians to offer effective tobacco dependence 
treatments and for health care systems to support and assist clinicians in making these 
treatments available to patients (Fiore et al., 2008).  Since over 70 percent of smokers 
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visit a primary care setting at least annually, primary care providers are in a key position 
to intervene with patients who use tobacco (Fiore et al., 2008).  However, many providers 
do not capitalize on this opportunity.  In 2010, less than half of adult smokers reported 
being advised by their health care professional to quit (CDC, 2011).   
 The guideline recommends a brief cost-effective intervention known as the 5As.  
The 5As include ask if the patient uses tobacco, advise the patient to quit, assess for 
willingness to quit, assist the patient in their quit attempt, and arrange for follow-up 
(Fiore et al., 2008).  Evidence suggests this intervention is not only effective in increasing 
smoking cessation but also increases overall satisfaction with health care (Conroy et al., 
2005; Fiore et al., 2008).  Implementing systems interventions and strategies that increase 
provider use of this brief intervention is an important part of tobacco cessation efforts.     
 A recent meta-analysis evaluated strategies and interventions to increase 
compliance with guidelines and the delivery of smoking cessation treatments in primary 
care (Papadakis et al., 2010).  The meta-analysis found multi-component interventions 
(Odds Ratio [OR] 2.2; 95% Confidence Interval [CI] 1.7-.8) and adjunct counseling (OR 
1.7; 95% CI 1.5-2.0) to be effective in increasing smoking cessation (Papadakis et al., 
2010).  This paper will expand on this meta-analysis, discuss in more detail its 
implications for practice, and provide suggestions for further research. 
Methods 
 
 Abstracts from all studies in the meta-analysis (n=38) as well as studies identified 
through an electronic database search were evaluated for inclusion and exclusion criteria.  
A literature search using CINAHL database with the keywords tobacco use OR smoking, 
cessation, and guidelines (n=173) and the keywords tobacco use OR smoking, cessation, 
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and improvement (n=214) was conducted.  Search limits were set for full text, peer 
reviewed English language publications from 2002 to 2014.  Selection criteria included 
studies that were set in the primary care setting, included interventions directed at 
providers, and assessed the effect interventions had on performance of two or more of the 
5As.  Studies were excluded if they focused on a specific population or disease state, 
such as pregnant women, assessed rates of medication use for smoking cessation rather 
than overall cessation rates, or focused on systems interventions.  A total of eleven 
studies from the systematic review and five studies from the database search met 
selection criteria.  
Results 
 
 Interventions used to improve compliance with smoking cessation guidelines fell 
into five distinct categories: vital sign stamp or electronic prompt, provider feedback, 
financial incentives, educational interventions, and multi-component interventions.  
Studies varied in design, sample size, and methods of data collection.  Table 1 provides a 
brief summary of each study including outcomes of each study as they relate to the effect 
the intervention had on the 5As of smoking cessation treatment.     
Vital sign stamp/electronic prompt 
 Four studies evaluated the effects of a vital sign stamp or electronic prompt on 
guideline implementation and smoking cessation (Milch, Edmunson, Beshansky, Griffith, 
& Selker, 2004; Piper et al., 2003; Rothemich et al., 2008; Szpunar, Williams, Dagroso, 
Engerg, & Chesney, 2006).  Piper et al. (2003), Rothemich et al. (2008), and Milch et al. 
(2004) used a vital sign stamp that included smoking status for intervention groups.  
Medical personnel who roomed the patient would stamp the chart and then document 
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smoking status.  Rothemich et al. (2008) found a significant increase in asking about 
tobacco use with 26.3% of control patients versus 66.0% of intervention patients (p<.001) 
reporting being asked about tobacco use.  There was also a significant increase in 
cessation counseling with 61.9% of intervention patients versus 53.4% of control patients 
(p=.04) reporting being counseled by their provider.  Piper et al. (2003) demonstrated a 
positive increase in staff asking patients about smoking status with a 30.9% increase in 
the intervention group versus a 9.6% increase in the control group (p=.002).  No effect 
was seen with seven day point prevalence abstinence rates, number of quit attempts, or 
advice, assistance, or arrangement of follow-up.  Neither study by Piper et al. (2003) nor 
Rothemich et al. (2008) reported odds ratios.    
 Milch et al. (2004) compared an enhanced intervention of a smoking assessment 
questionnaire (SAQ) to utilizing a vital sign stamp and a control group.  The SAQ 
consisted of a six item questionnaire filled out by the patient in the waiting room prior to 
the visit and a section for the clinician to assess patient's readiness to quit and document 
cessation interventions.  The SAQ group had significantly higher rates of smoking status 
documentation (91% vs. 86% vs. 49%; p<.001), cessation advice (47% vs. 38% vs. 30%; 
p=.014), and self-reported cessation (12% vs. 2% vs. 4%; p<.001) as compared to the 
vital sign stamp group and control group respectively.  Patients were considered to have 
quit smoking if at the time of phone interview follow-up (nine to ten months after the 
intervention) they stated they were no longer smoking, could identify a quit date, and had 
not smoked since their quit date.  However when comparing the SAQ arm directly to the 
control arm there was a more significant rate of cessation advice (p<.005).  Odds ratios 
were not reported.  
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 The fourth study conducted by Szpunar et al. (2006) utilized a similar study 
design to Milch et al. (2004).  However Szpunar et al. (2006) implemented their 
interventions as part of the electronic medical record (EMR).  In the first intervention 
arm, the medical assistant or nurse would assess tobacco use status and willingness to 
quit as part of the check in process.  This intervention resulted in significantly higher 
rates of asking about tobacco use (OR 1.443, 95% CI 1.240-1.679; p<.009).  In the 
second intervention arm, clinicians would be prompted to document on advising and 
assisting the patient to quit and arranging follow-up based on the patient's tobacco use 
status and willingness to quit.  Higher rates of compliance with all 5As were noted after 
implementation of the second intervention arm, however only rates of asking (OR 2.008, 
95% CI 1.710-2.359; p<.001) and assessing (OR 1.585, 95% CI 1.124-2.235; p=.01) 
were statistically significant (Szpunar et al., 2006).  
 Overall the studies by Milch et al. (2004), Piper et al. (2003), Rothemich et al. 
(2008), and Szpunar et al. (2006) demonstrate adding tobacco use status to vital sign 
documentation can increase rates of asking about tobacco use.  Identifying tobacco users 
is a critical step in the 5A process as it must be completed prior to implementation of the 
other 4As.  Milch et al., (2004) and Szpunar et al. (2006) demonstrated that adding an 
enhanced intervention with further prompts or questions related to tobacco use can 
increase rates of giving advice and assessing willingness to quit.   
Provider Feedback  
 Two studies used provider feedback to improve compliance with utilizing the 5As 
method (Andrews, Tingen, Waller, & Harper, 2001; Bentz et al., 2007).  Bentz et al. 
(2007) gave providers in the intervention arm monthly reports from the electronic health 
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record detailing individual performance of asking, assessing, advising, and assisting with 
tobacco cessation.  Each clinician's performance was compared to the local clinic average 
and a standard benchmark of care.  Twelve monthly reports were given during the study 
period.  During a twelve month follow-up period electronically documented rates of 
advising (OR 1.36, 95% CI 1.33-1.39), assessing (OR 1.63, 95% CI 1.53-1.69), and 
assisting with cessation (OR 1.92, 95% CI 1.78-2.08) were significantly improved 
(p<.001) in the intervention arm as compared to the control arm (Bentz et al., 2007). 
 Andrews et al. (2001) found a significant improvement in advising (p=.05), 
assisting (p=.001), and arranging follow-up (p=.001) after written individual and team 
feedback reports were given to providers. Rates of giving advice improved from 79.6% at 
baseline to 100% after feedback.  Rates of assistance increased from 32.5% at baseline to 
89.3% and arrangement of follow-up increased from 0% at baseline to 17.8% after 
feedback.  Odds ratios were not reported.  This study was conducted based on the 1996 
guideline which did not include assess willingness to quit (added in 2000 guideline).  
Reports were generated from chart reviews of all patients seen by each provider in a 4 
week time span.  Prior to the study, a vital sign stamp that included smoking status had 
been implemented.  This intervention resulted in 100% compliance with asking about 
smoking status (Andrews et al, 2001).   
 The results of Andrews et al. (2001) and Bentz et al. (2007) indicate that 
providing periodic feedback to providers on performance of the 5As can increase 
compliance with the 5A method.  In addition, Andrews et al. (2001) demonstrated that 
adding written feedback to a vital sign stamp intervention may result in full 
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implementation of tobacco use interventions.  Unfortunately, the study did not measure 
the effect of feedback on assessing willingness to quit.   
 Both studies also conducted educational training prior to producing feedback 
reports.  Bentz et al. (2007) held 30 minute training sessions for all providers and staff in 
both the intervention and control groups on cessation strategies including motivational 
counseling, approved pharmacotherapy, and referrals to the state quit line.  Andrews et al. 
(2001) held a 90 minute educational session on tobacco dependence, the four As, 
treatment strategies, and clinical practice guidelines.  Andrews et al. (2001) reported no 
significant effects of the educational session on provider performance of advising, 
assisting, or arranging follow-up.  Bentz et al. (2007) did not measure for any effect the 
educational session had on guideline compliance. 
Financial Incentives 
 Providing financial incentives to medical group practices or clinicians for 
compliance with tobacco cessation guidelines may increase identification of tobacco use 
status (Roski et al., 2003) and the provision of advice to quit (Coleman, Lewis, Hubbard, 
& Smith, 2007).  Roski et al. (2003) set target rates at 75% for documentation of tobacco 
use status and 65% for provision of advice to quit.  Bonus payments of $5,000 to $10,000 
were given to each clinic that met or exceeded the target rates.  Documentation of 
tobacco use status significantly improved by 14.1% in the incentive group versus 6.2% in 
the control group (p=.0009).  There was no statistically significant difference between the 
control group and financial incentive group for advising or assisting smokers to quit 
despite the incentive for provision of advice.  Similar seven day point prevalence 
abstinence rates were noted with self reported quitting rates of 19.2% and 22.4% in the 
 30 
control and incentive groups, respectively (Roski et al, 2003).  Odds ratios were not 
reported.  The authors of the study speculate that the overall lack of effect of financial 
incentives may be due to lack of knowledge of the incentives and diversion of the 
providers' attention to other pressing issues such as increasing productivity and 
decreasing costs (Roski et al., 2003).   
 Coleman at al. (2007) examined rates of smoking status documentation, receipt of 
smoking cessation advice, and prescriptions for nicotine addiction treatments before and 
after a contract was established for general practitioners in the United Kingdom.  The 
contract provided financial incentives for general practitioners that met certain target sets 
within a defined Quality Outcome Framework.  An example of a target that would 
qualify clinicians for incentives is the smoking status of at least 75 percent of patients 
aged 15-75 years is recorded in the last five years.  Documentation of smoking status 
(rate ratio [RR] 1.88, 95% CI 1.87-1.89) and brief smoking cessation advice (RR 3.03, 
95% CI 2.98-3.09) increased after implementation of financial incentives.  However since 
there was no target set for prescribing nicotine addiction medications, the contract 
appeared to have little effect on prescription of nicotine addiction products (Coleman et 
al., 2007).  Overall, financial incentive programs may improve rates of documenting 
tobacco use status and giving advice to quit, however the feasibility and cost of this 
intervention may limit its implementation in primary care when compared to less costly 
interventions such as a vital sign stamp.   
Educational interventions 
 Three studies implemented educational interventions for providers to increase 
clinician compliance with the 5As (Caplan, Stout, & Blumenthal, 2011; DePue et al., 
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2002; Unrod et al., 2007).   All three studies showed promising results in increasing 
compliance with 5A implementation using education and training.  Both Caplan et al. 
(2011) and Unrod et al. (2007) demonstrated favorable results with significant increases 
in rates of advising (p<.0001), assessing (p<.0001), assisting (p<.0001), and arranging 
follow-up (p<.0001).  Caplan et al. (2011) conducted two 90 minute training sessions for 
clinicians and support staff on the Public Health Service tobacco use guideline and 
Pathways to Freedom, a program specific to African-American smokers.  Percentage of 
charts that documented evidence of advice (12% to 29%), assessment (5% to 24%), 
assistance (6% to 21%), and arrangement of follow up (6% to 17%) increased 
significantly after the intervention (p<.0001).  All charts had documentation of smoking 
status (asked) both pre- and post-intervention.  Odds ratios were not reported. (Caplan et 
al., 2011)   
 Unrod et al. (2007) conducted 40 minute individual training sessions with each 
physician on smoking cessation counseling using the 5As method.  In addition to the 
educational intervention, tailored reports were generated from a pre-visit assessment that 
included patient smoking-related information such as readiness to quit, smoking status, 
and pros and cons of smoking.  These reports were given to the patient and physician at 
the time of the visit (Unrod et al., 2007).  Patients seen by physicians in the intervention 
group were more likely to be assessed about their willingness to quit (OR 5.06, 95% CI 
3.22-7.95, p<.0001), given advice to quit (OR 2.79, 95% CI 3.22-7.95; p<.0001), and 
have follow-up arranged (OR 8.14, 95% CI 3.98-16.68; p<.0001).  Patients in the 
intervention group also had a higher likelihood of receiving assistance with quitting in the 
form of setting goals (OR 4.31, 95% CI 2.59-7.16; p<.0001), receiving written materials 
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(OR 5.14, 95% CI 2.60-10.14; p<.0001), discussing medications (OR 4.72, 95% CI 2.90-
7.68; p<.0001), and being referred to a smoking cessation program (OR 6.48, 95% CI 
3.11-13.49; p<.0001). 
 DePue et al. (2002) held three one hour training sessions that included 
information on effective tobacco interventions, system interventions to increase 
intervention delivery, and tobacco cessation counseling skills.  The sessions were offered 
to all staff with patient contact.  The first session included chart review feedback of 
baseline documentation of the 4As (based on 1996 guideline) and a review of the 
guideline.  The second session reviewed tobacco use identification approaches and 
assisted with problem solving around system barriers.  The third session focused on 
counseling skills and included role playing with challenging case examples.   
 Overall, rates of asking about tobacco use (OR 3.00, 95% CI 1.19-7.5) and 
advising patients to quit (OR 1.29, 95% CI 0.69-2.43) did increase after the educational 
intervention.  However, statistically significant increases were only evident in certain 
visit types (p-values not reported).  Yearly physicals and first time visits were related to 
an increased likelihood of asking about tobacco use (yearly physical: OR 35.83, 95% CI 
24.90-51.57; first visit: OR 9.82, 95% CI 6.62-14.57) and advising to quit (yearly 
physical: OR 2.43, 95% CI 1.53-3.87; first visit: OR 2.17, 95% CI 1.26-3.76) as 
compared to medical follow up visits (DePue et al., 2002).  This is most likely due to the 
fact physicals and initial visits are more focused on general health promotion and 
prevention rather than specific medical problems.   
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Multi-component interventions 
 Several studies combined the previously mentioned interventions to assess for 
effectiveness on guideline compliance and smoking cessation rates (Hung & Shelley, 
2009; Katz, Muehlenbruch, Brown, Fiore, & Baker, 2004; Tingen, Andrews, Waller, & 
Daniel, 2004; Twardella & Breener, 2007; Young, D'Este, & Ward, 2002).  Katz et al. 
(2004) utilized a vital signs stamp, a tutorial and feedback for intake clinicians, free 
nicotine replacement therapy for patients, and proactive telephone counseling.  The 
tutorial and feedback for intake clinicians focused on assessing smoking status, delivering 
a brief cessation message, and providing assistance to individuals who expressed 
willingness to quit.  After the intervention was implemented, patients at the intervention 
clinic sites were more likely to be asked about smoking status (OR 3.1, 95% CI 1.2-8.2; 
p=.02), be assessed for willingness to quit (OR 6.4, 95% CI 3.7-10.8; p<.001), and 
assisted with cessation (p<.001) than patients at control clinic sites.  Assisting with 
cessation was defined as helping set a quit date (OR 33, 95% CI 11-100), distributing 
cessation literature (OR 21, 95% CI 8.8-49), or discussing pharmacotherapy (OR 3.9, 
95% CI 2.5-6.3).  No statistically significant difference was noted in advice to quit (OR 
1.3, 95% CI 0.8-2.3; p=.29).  However, the positive effect on quit attempts (OR 1.4, 95% 
CI 0.98-1.9; p=.06), two month quit rates (OR 3.3, 95% CI 1.9-5.6, p<.001), six month 
quit rates (OR 1.1, 95% CI 1.2-2.6; p=.009), and continuous abstinence (OR 3.4, 95% CI 
1.8-6.3; p<.001) was statistically significant.  Quit rates were determined based on self-
reported abstinence over the past seven days at the two and six month follow-ups.  
Continuous abstinence was defined as self-reported abstinence at both the two and six 
month follow up (Katz et al., 2004).   
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 Twardella and Brenner (2007) combined education, financial incentives, and 
reimbursement for nicotine replacement therapy or bupropion in a 2×2 factorial design.  
Medical practices were randomized to receive usual care, training plus incentive (TI), 
training plus medication reimbursement (TM), or training, medication reimbursement, 
and incentives (TI + TM).  The financial incentive consisted of a provider payment of 
130 euros for each patient who was smoke-free at twelve month follow-up.  The 
educational training consisted of a two hour session on stages of change, smoking 
cessation counseling, and pharmacological interventions for smoking cessation.  All 
participants in the study were asked by the researchers about smoking status and 
readiness to quit.  The intervention only significantly affected assistance to quit in regards 
to providing medication (nicotine replacement therapy or bupropion [OR 3.33, 95% CI 
1.78-6.20; p=.003]).  However, the study did report patients in the TM group (OR 4.77, 
95% CI 2.03-11.22; p=.046) and TI + TM group (OR 5.43, 95% CI 1.48-19.84; p=.02) 
had an increased odds of self-reported and serum cotinine verified smoking cessation at 
12 months follow-up (Twardella & Brenner, 2007).  Overall the study indicates that 
combining provider education with reimbursement for cessation medications may be 
effective in increasing cessation rates.   
 Tingen et al. (2004) completed a three phase study of the effects of an educational 
intervention, written provider feedback, a tobacco use chart label, and clinician reminders 
on documentation of asking, advising, assisting, and arranging.  The first phase was a 
baseline medical record review of the 4As (study conducted prior to 2000 guideline and 
addition of assess willingness to quit).  The second phase included a 60 minute 
educational intervention for providers on the Public Health Service guideline and the 
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research project.  Providers were also given a resource packet with a copy of the 
guideline and other useful cessation information and instructed on use of the chart label.  
An information session for healthcare staff was also conducted that presented information 
on the research project and use of the chart label.  Medical record reviews were 
conducted 5 weeks after the educational intervention.  During phase III written feedback 
based on phase I and II medical record review was given to clinicians.  Feedback 
included individual and practice performance of the 4As.  Email and flyer reminders were 
distributed to clinicians to encourage continued use of the guideline.  Additional medical 
record reviews were conducted eight to ten weeks after the reminders.   
 Overall significant increases in rates of asking, advising, and assisting (p<.0001) 
were noted after the interventions.  The most drastic increases in asking (69% to 97.6%), 
advising (10% to 80%), and assisting (5% to 80%) were seen between phase I and phase 
II of the project. This demonstrates that the educational component and chart label had 
the most significant impact on delivery of the 4As.  Odds ratios were not reported 
(Tingen et al., 2004). 
 Another study by Young et al. (2002) focused on improving physician advice to 
quit by implementing an academic detailing intervention, audit and feedback, and 
providing clinician, practice, and patient resources.  Provider training focused on 
evidence-based cessation strategies and national clinical practice guidelines. Specific 
cessation strategies discussed in training included giving unequivocal advice to quit, 
negotiating a quit date, practical suggestions on how to quit, reinforcing verbal advice 
with written materials, recommending NRT, and arranging follow up.  Resources for 
providers included a training video, copy of the guidelines, and prompt sheets to manage 
 36 
smokers’ reasons for not quitting.  Practice resources included medical record prompts 
and reminders.  Free nicotine gum starter packs and brochures were provided to patients.  
A maximum six month time period elapsed between baseline data collection and post-test 
data collection.   
 Patient recall rates of asking about smoking status and giving advice were 
significantly higher in the intervention group compared to the control group. However the 
confidence intervals around the adjusted odds ratios overlapped indicating there was no 
significant differences in the size of change in each group.  Patient recall rates of 
receiving advice about nicotine replacement therapy was statistically increased (nicotine 
patch: OR 2.70, 95% CI 1.44-4.40; p=.0056 and nicotine gum: OR 5.31, 95% CI 2.68-
10.51; p=.0002) in the intervention group as compared to the control group.  Medical 
record documentation of smoking status (intervention group: OR 2.47, 95% CI 1.75-3.5; 
control group: OR 2.88, 95% CI 1.18-7.04) and smoking cessation advice (intervention 
group: OR 3.33, 95% CI 1.39-7.97; control group: OR 1.40, 95% CI 0.41-4.79) was not 
significantly (p>0.1) improved in the intervention group than the control group (Young et 
al., 2004).   
Hung & Shelley (2009) distributed clinic and provider surveys to 497 primary 
care providers and 60 primary care clinics to examine how the chronic care model (CCM) 
improves provider delivery of the 5As of tobacco cessation services.  The CCM is a 
systems-level quality improvement framework that consists of six key concepts: decision 
support, health systems and organization of health care, community resources, self-
management support, enhanced delivery system designs, and clinical information 
systems.  Providers practicing in clinics with self-management support (OR 2.98, 95% CI 
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1.11-7.98; p=.031), clinical information systems (OR 5.62, 95% CI 1.63-19.36; p=.008), 
and enhanced delivery system design (OR 2.04, 95% CI 1.40-2.98; p=.001) were 
significantly more likely to perform all 5A services (p<.05).   
For their particular study Hung & Shelley (2009) defined self management 
support as a formal system to assist in the delivery of the 5As such as a vital sign stamp 
or medical record prompt. Clinical information systems were operationalized by whether 
a clinic maintained a registry of tobacco users and the extent to which providers 
documented tobacco-related information in the medical record.  Enhanced delivery 
system design included group visits or activities for smokers ready to quit, use of 
dedicated staff to screen or counsel tobacco users, and a clinic champion to coordinate 
cessation activities.  
Overall the study demonstrated that clinics following the chronic care model 
adhere more closely to tobacco use guidelines and have greater compliance with 5A 
delivery.  Use of clinical information systems was the strongest correlate of 5As delivery.  
This suggests that population-based approaches, such as use of patient registries to 
monitor and implement tobacco use treatments as well as initiating electronic medical 
records and requiring documentation of smoking status, are effective in increasing 5A 
delivery  (Hung & Shelley, 2009).   
When comparing multi-component intervention studies, three studies (Hung & 
Shelley, 2009; Katz et al., 2004; Tingen et al., 2004) clearly demonstrated significant 
(p<.05) effects of 5A implementation.  All of these studies implemented a chart label or 
vital sign stamp with other systems interventions such as education, feedback, or use of 
dedicated staff to implement tobacco use interventions.  The other two studies (Twardella 
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& Brenner, 2007; Young et al., 2002) did not include a chart label or vital sign stamp.  As 
stated previously the first step in implementation of the 5A method is the identification of 
tobacco users.  Perhaps increased rates of asking about tobacco use within these studies 
would have yielded improved results in the implementation of the other 4As.   
Discussion 
 
 Utilizing effective interventions to increase provider compliance with tobacco use 
guidelines has been found to increase smoking cessation rates.  Determining the best 
interventions to utilize may vary by provider, patient, or practice.  By reviewing current 
literature and selecting evidence-based strategies, providers may be better equipped to 
assist their patients who are tobacco users.   
 Recommendations for practice based on the previously discussed studies are 
summarized in Table 2.  The vital sign stamp or chart label has been proven to be 
effective in increasing documentation of tobacco use status (Andrews et al, 2001; Hung 
& Shelley, 2009; Katz et al., 2004; Milch et al., 2004; Piper et al., 2003; Rothemich et al., 
2008; Szpunar et al., 2006; Tingen et al., 2007) .  The first step in intervening with a 
tobacco user is to identify that individual.  Implementing a vital sign stamp is a low cost 
intervention that increases the identification of tobacco users.  More studies on electronic 
prompts, such as the study by Szpunar et al. (2006), may help identify ways in which 
electronic health records can be developed to increase compliance with tobacco use 
guidelines.  Clinics with electronic health records should attempt to add tobacco use 
status to vital sign documentation and check-in screens.   
 Provider feedback appears to be an effective intervention to increase provider 
compliance with tobacco use guidelines (Andrews et al., 2001; Bentz et al., 2007; Depue 
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et al., 2002; Katz et al., 2004; Tingen et al., 2004; Young et al., 2002).  However, the best 
method and frequency of feedback has not yet been identified.  Practices may elect to 
survey providers to determine the method and frequency of feedback that will be best 
received.  Feedback may include clinic and individual performance of the 5As and could 
be in the form of written reports, emails, or visible charts within the clinic.  Cost of 
producing feedback reports should also be considered when selecting method and 
frequency of feedback.  Growing use of electronic medical records may enable clinics to 
more easily generate reports on provider performance of tobacco use guideline 
recommendations.    
 Almost half of the studies demonstrated a positive effect of provider education on  
compliance with the 5As and overall cessation rates (Caplan et al., 2011; DePue et al., 
2002; Katz et al., 2004; Tingen et al., 2004; Twardella & Brenner, 2007; Unrod et al., 
2007; Young et al., 2002).  Length, content, frequency, intended audience, and method 
(individual vs. group) of training sessions varied among studies.  Further research is 
needed to determine specific educational components to include in training.   
 Currently the Public Health Service tobacco use guideline recommends that all 
clinicians receive training on methods to motivate and assist smokers to quit (Fiore et al., 
2008).  Meta-analysis for the 2008 guideline demonstrated a positive effect (OR 3.2, 95% 
CI 2.0-5.2) of clinician training on rates of providing tobacco use treatment (assist).  
Additional meta-analyses from the guideline demonstrated that clinician training when 
combined with a charting system, such as a vital sign stamp, increased the rates of 
tobacco use assessment (ask) [OR 2.1, 95% CI 1.9-2.4], setting a quit date [OR 5.5, 95% 
 40 
CI 4.1-7.4], providing materials (assist) [OR 4.2, 95% CI 3.4-5.3], and arranging follow-
up (arrange) [OR 2.7, 95% CI 1.9-3.9].   
 A recent Cochrane review revealed similar results.  Carson et al. (2012) found 
that health professionals that received training were more likely to help their patients with 
setting a quit date [OR 4.98, 95% CI 2.29-10.86; p<.0001], provide self-help materials 
(assist) [OR 3.52, 95% CI 1.90-6.52; p<.0001], provide cessation counseling (advice) 
[OR 2.28, 95% CI 1.58-3.27; p<.00001], and schedule follow up appointments (arrange) 
[OR 3.34, 95% CI 1.51-7.37; p<.00001].  Training also significantly increased point 
prevalence of smoking cessation (OR 1.36, 95% CI 1.20-1.55; p=.004) and continuous 
abstinence (OR 1.60; 95% CI 1.26-2.03; p=.03). Point prevalence is generally defined as 
smoking abstinence for the last seven days whereas continuous abstinence is no smoking 
for an extended amount of time, generally six to twelve months (Carson et al., 2012).  
The evidence from this literature review as well as recent meta-analyses clearly 
establishes the important role that health provider education and training has in increasing 
tobacco use interventions. 
 Using financial incentives to increase compliance with tobacco use guidelines has 
had mixed results in studies (Coleman et al., 2007; Roski et al., 2003; Twardella & 
Brenner, 2007).  Clinics should focus on interventions that will promote sustained 
compliance with tobacco use guidelines.  Many clinics may lack the resources to 
maintain financial incentive programs, thereby diminishing motivation to comply with 
guideline recommendations.   
 Overall combining multiple interventions may be the most effective approach to 
increase compliance with guideline recommendations.  Clinics should consider available 
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resources, patient population, and provider experience, knowledge, and skills related to 
tobacco use treatment when considering which interventions to implement.  Combining 
vital sign stamps, educational components, and feedback have been shown to increase 
rates of asking, assessing, advising, and assisting (Katz et al., 2004; Tingen et al., 2004).   
Few studies demonstrated effective interventions in increasing arrangement of 
follow-up (Andrews et al., 2001; Caplan et al., 2011; Hung & Shelley, 2009; Szpunar et 
al., 2006; Unrod et al., 2007).  Further research is needed to determine strategies effective 
in increasing rates of arranging follow-up.  Poor compliance with arranging follow-up 
may be correlated to a lack of community resources, as three of the five studies that had a 
significant effect on arranging follow-up facilitated referrals to quit lines or had access to 
specialized clinics (Andrews et al., 2001; Caplan et al., 2011; Szpunar et al., 2006).   
Continued research about the feasibility, utility, and cost-effectiveness of various 
interventions to increase compliance with tobacco use guideline recommendations should 
be conducted.  Providers and clinic administrators should employ evidence-based 
strategies to increase compliance with guideline recommendations and evaluate 
outcomes.  Specific strategies that have been shown to be effective include health care 
provider education (Caplan et al., 2011; DePue et al., 2002; Fiore et al., 2008; Katz et al., 
2004; Tingen et al., 2004; Twardella & Brenner, 2007; Unrod et al., 2007; Young et al., 
2002), charting systems such as a vital sign stamp (Andrews et al., 2001; Hung & 
Shelley, 2009; Katz et al., 2004; Milch et al., 2004; Piper et al., 2003; Rothemich et al., 
2008; Szpunar et al., 2006; Tingen et al., 2007), and performance feedback (Andrews et 
al., 2001; Bentz et al., 2007; Katz et al., 2004; Tingen et al., 2004; Young et al., 2002).  
Clinical practice guidelines, such as the Public Health Service guideline on Treating 
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Tobacco Use and Dependence, provide a tool for clinicians to give patients evidence-
based, quality care.  Compliance with guideline recommendations is an essential step in 
improving health outcomes.   
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Table 1 Brief summary of included studies 
 Study Design Sample size Setting Effect on 5As 
Vital sign 
stamp 
Rothemich 
et al., 2008 
Cluster 
randomized 
controlled trial 
6,729 patient 
surveys 
(1,149 
smokers) 
18 primary care 
practices 
↑ Advice  
↑ Ask  
 
Piper et al., 
2003 
Nonrandomized 
controlled trial 
with pre-test, 
post-test design 
9,439 patient 
surveys 
(1,611 
smokers) 
5 primary health 
care clinics ↑ Ask  
 
Milch et al., 
2004 
Prospective 
nonrandomized 
controlled trial 
1,265 patient 
visits 
(medical 
record 
review) 
245 patient 
surveys (self-
reported 
cessation) 
Hospital-based 
adult primary 
care practice 
↑ Ask  
↑ Advice  
 
Szpunar et 
al., 2006 
Pre-post cross 
sectional design 
5,334 patient 
surveys (pre-
implementatio
n) 
3,970 patient 
surveys (post-
implementatio
n) 
6 primary care 
clinics 
↑ Ask  
↑ Assess 
 
Provider 
feedback 
Bentz et al., 
2007 
Cluster 
randomized 
clinical trial 
102,915 
patient 
records 
(15,435 
smokers) 
19 primary care 
clinics 
↑ Advice  
↑ Assess 
↑Assist 
 
 
Andrews at 
al., 2001 
Quasi-
experimental 
study 
637 patient 
records 
Veterans Affairs 
Medical Center 
primary care 
center 
↑ Advice 
↑Assist ↑ 
Arrange 
Financial 
incentives Roski et al., 
2003 
3 condition 
group 
randomized 
efficient 
evaluation 
design 
8812 patient 
surveys (1736 
smokers) 
37 primary care 
clinics of large 
multi-specialty 
medical group 
practice 
↑ Ask  
 
Coleman et 
al., 2007 
Longitudinal 
observational 
study 
1,607,782 
patient 
records 
Database of 
routine United 
Kingdom 
primary care 
records 
↑ Ask  
↑ Advice  
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Provider 
education 
Caplan et 
al., 2011 
Pre- and post-
test 
observational 
study 
308 patient 
records 
Georgia 
community 
health centers & 
primary care 
clinics serving 
predominantly 
African-
American 
population 
↑ Advice  
↑ Assess 
↑Assist 
↑Arrange 
 
 
Unrod et 
al., 2007 
Randomized 
controlled trial 
518 patient 
surveys 
Primary care 
clinics within a 
large New York 
City managed 
care 
organization 
↑ Advice 
↑Assess 
↑Assist 
↑Arrange 
 
 
DePue et 
al., 2002 
Pre- and post-
test 
observational 
study 
1798 patient 
visits (pre) 
1591 patient 
visits (post) 
891 patient 
visits (1 year 
follow up) 
14 community 
health centers in 
Rhode Island 
↑ Ask  
↑Advice  
Multi-
component 
intervention 
Katz et al., 
2004 
Randomized 
controlled trial 
2163 patient 
surveys 
8 community 
based primary 
care clinics in 
southern 
Wisconsin 
↑ Ask  
↑Assess 
↑Assist 
 
 Twardella 
& Brenner, 
2007 
Cluster 
randomized 
trial, 2×2 
factorial design 
577 patient 
surveys 
82 medical 
practices in 
Germany 
↑ Assist  
 
 
Tingen et 
al., 2004 
Repeated 
measures design 
300 patient 
records 
Large primary 
care practice 
within an 
academic 
medical center 
↑ Ask  
↑ Advice 
↑ Assist 
 
 
Young et 
al., 2002 
Cluster 
randomization 
trial 
1788 patient 
surveys 
(baseline), 
1727 patient 
surveys (post-
test), 1023 
patient 
records 
39 family 
practice clinics 
in Australia 
↑Advice  
 
Hung & 
Shelley, 
2009 
Cross-sectional 
survey design 
497 provider 
surveys 
60 primary care 
clinics serving 
low-income 
individuals in 
New York City 
↑ Ask 
↑Advice 
↑Assess 
↑ Assist 
↑ Arrange 
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Table 2 Recommendations for practice 
Recommendation Rationale 
Primary care practices should include 
tobacco use status as part of vital sign 
documentation. 
Documenting tobacco use status with vital signs has 
been shown to increase asking about tobacco use 
(Andrews et al., 2001; Hung & Shelley, 2009; Katz et al., 2004; Milch et 
al., 2004; Piper et al., 2003; Rothemich et al., 2008; Szpunar et al., 2006; 
Tingen et al., 2007).  
Brief educational interventions 
providing an overview of guideline 
recommendations and effective tobacco 
use interventions should be 
implemented in primary care clinics. 
The guideline suggests that all clinicians and clinicians-
in-training should be trained on effective methods in 
assisting tobacco users to become motivated to quit and 
successfully quit (Fiore et al., 2008). Studies have also 
demonstrated the effectiveness of provider training on 
improving rates of 5A compliance (Caplan et al., 2011; Carson 
et al., 2012; DePue et al., 2002; Katz et al., 2004; Tingen et al., 2004; 
Twardella & Brenner, 2007; Unrod et al., 2007; Young et al., 2002). 
Feedback reports of provider 
performance of the 5As should be 
provided to primary care providers at 
regular intervals.   
Provider feedback has been shown to increase 
compliance in asking, assessing, assisting, and advising 
and may help identify the need for additional 
interventions if performance is poor (Andrews et al., 2001; 
Bentz et al., 2007; Katz et al., 2004; Tingen et al., 2004; Young et al., 
2002). 
More than one of the above 
interventions should be utilized. 
Combining interventions may increase likelihood of 
compliance with all 5As.  The guideline suggests that 
full implementation of all 5As may produce superior 
results than partial implementation (Fiore et al., 2008) 
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Abstract 
Background: Improving the documentation and delivery of evidence-based tobacco use 
interventions in primary care is essential to increasing the number of successful smoking 
cessation attempts and reducing tobacco-related morbidity and mortality.   
 
Purpose: The aim of this study was to identify the frequency with which primary care 
providers document implementation of tobacco use guideline interventions and evaluate 
the providers' perception of the value and effectiveness of providing education and 
feedback to them on the tobacco use guideline.   
 
Methods: Data for this descriptive study were collected from a retrospective chart review 
and provider survey.  Electronic medical records at a primary care clinic were reviewed 
to assess provider documentation of the first 3As of the 5A method described in the 
Public Health Service tobacco use and dependence guidelines.  A provider survey 
assessing provider perceptions of an educational session and written feedback was 
distributed to four primary care providers.   
 
Results: The study indicated that documentation of tobacco use interventions in one 
primary care clinic is poor and provision of education and feedback to providers had an 
overall favorable rating on their perceived motivation, knowledge, and confidence in 
intervening with tobacco users.  Subjective findings from the study revealed several 
systems issues within the clinic including a lack of knowledge and skills among support 
staff, poor usability within the electronic medical record, and lack of a structured charting 
system.   
 
Conclusion:  Suggestions for improvement in the study clinic include adding tobacco use 
status to vital sign documentation, improving the electronic health record to include 
tobacco intervention decision support prompts, and adopting a clinic policy that addresses 
the process and expectation for tobacco use identification, intervention, and 
documentation.  Future research should be directed at improving electronic health records 
to streamline and facilitate the documentation and implementation of tobacco cessation 
interventions.  Research should also focus on specific educational and feedback 
components that improve adherence to tobacco use guidelines.   
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Delivery of Evidence-based Tobacco Use Interventions in Primary Care 
 Tobacco use cessation is a highly important public health issue as it is the only 
proven method to reduce the heavy economical and health-related burdens of tobacco use 
in the U.S. population.  In a 2010 survey nearly 70% of smokers surveyed indicated a 
desire to quit smoking with over half reporting a quit attempt in the last year (CDC, 
2011).  However less than ten percent of surveyed smokers reported a successful smoking 
cessation attempt (CDC, 2011).  Tobacco use cessation often requires multiple attempts 
and has shown to be more successful with the use of medication and counseling (Fiore et 
al., 2008).   
 It is essential that health care providers identify tobacco users and provide evidence-
based treatment options for smoking cessation.  Evidence demonstrates that health care 
provider interventions can have a positive impact on smoking cessation rates.  A recent 
Cochrane review of studies involving over 31,000 smokers demonstrated a one to three 
percent increase in successful cessation at six month follow up after brief minimal advice 
from a physician (Stead et al., 2013).  Additional meta-analyses have demonstrated 
physician advice to quit, including interventions lasting less than three minutes, increases 
abstinence rates (Fiore et al., 2008). 
 Clinical practice guidelines can assist providers in delivering evidence-based care 
when intervening with a tobacco user.  In 2008, the Public Health Service published the 
clinical practice guideline Treating Tobacco Use and Dependence: 2008 Update which 
was developed to provide evidence-based recommendations on simple, adaptable 
interventions and treatments that health care providers can utilize in a variety of settings 
to help tobacco users overcome their addiction (Fiore et al., 2008).  The guideline 
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recommends the use of the 5As method: ask about tobacco use, advise to quit, assess 
willingness to quit, assist in the quit attempt, and arrange follow-up (Fiore et al., 2008).  
According to the guideline the first 3As (ask, advise, and assess) should be utilized at 
every patient encounter.  Despite evidence that this intervention is effective (Fiore et al., 
2008; Gorin & Heck, 2004; Stead et al., 2008) performance of the 5A method is 
inconsistent.  Studies have demonstrated varied rates of adherence to the 5A method with 
rates of asking between 62 to 90%, rates of advice between 20.9 to 89%, rates of 
assessment between 23 to 81%, rates of assistance between 7.6% to 76%, and rates of 
arranging follow up between 2 to 31% (Conroy et al., 2005a; Conroy et al., 2005b; Jamal, 
Dube, Malarcher, Shaw & Engstrom, 2012; Quinn et al., 2005).  This wide range of 
delivery of the components of the 5As model may be partially attributed to poor 
documentation rates.  Conroy et al. (2005a) noted that providers and patients both report 
higher rates of compliance with the guideline than is documented in the medical record.  
Despite the wide variability, it is evident that many tobacco users are not receiving the 
recommended assistance from their health care providers.   
 In order to improve adherence to tobacco use guideline recommendations, evidence-
based interventions that increase delivery of the 5As model should be implemented.  A 
recent meta-analysis found that multi-component interventions were most effective in 
increasing adherence to guideline recommendations and improving smoking cessation 
outcomes (Papadakis et al., 2010).  Though it is uncertain which specific components 
lead to higher cessation rates, all multi-component intervention studies included in the 
meta-analysis provided clinician training.  Provider training, alone or when combined 
with performance feedback, has been shown to be effective in improving documented 
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rates of 5A delivery in the primary care setting (Andrews, Tingen, Waller, & Harper, 
2001; Bentz et al., 2007; Carson et al., 2012; Fiore et al., 2008). 
 Evidence from the literature brings forth two main questions: How often are primary 
care providers delivering and documenting the components of the 5As model?  If 
compliance with tobacco use guideline recommendations is lacking can provider 
feedback and a brief educational intervention improve provider knowledge, motivation, 
and confidence in regard to intervening with tobacco users?  This study focused on the 
first 3As since the guideline recommends that every patient, regardless of reason for visit, 
be delivered the first 3As. 
Objectives 
 The overall goal of the study was to aid primary care providers in identifying gaps in 
practice and ways in which they can improve the implementation of tobacco use 
guidelines.  The first objective of this study was to identify the frequency with which 
primary care providers implement the first 3As (ask, advise, assess) as evidenced by chart 
documentation.  The second objective was to evaluate the providers' perception of the 
value and effectiveness of written feedback based on chart review data and an 
educational session on the 5As model and tobacco use guideline.   
Methods 
 The study followed a non-experimental descriptive design that was composed of two 
parts.  The first part of the study was a retrospective chart review of electronic charts at a 
family practice clinic.  Approximately 500-600 adult patients are seen at the clinic in a 
two week period.  Therefore as recommended by the World Health Organization for 
quality improvement the principal investigator identified an approximate sample size of 
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127 charts (Agins, Seung, & Heiby, 2008).  To obtain approximately 127 charts for 
review the principal investigator (PI) selected every fourth chart of patients seen at the 
clinic by a participating non-obstetrician/gynecologist (OB/GYN) primary care provider 
from July 29, 2013 to August 9, 2013.  The PI then reviewed the patient's initial visit note 
and current visit note to assess for inclusion criteria, which consisted of age 18 and older 
and identified as a tobacco user.  The initial visit note was defined as the first visit that 
was documented in the electronic health record.  The current visit note was defined as the 
visit that occurred between July 29, 2013 and August 9, 2013.  All electronic records that 
met inclusion criteria were included in data collection for the chart review.   
 Data was collected from the current visit note of all patients that met inclusion 
criteria (Appendix B).  Demographic data such as age, gender, insurance, and race as well 
as date of visit, name of provider, and chief complaint was collected from the chart 
review.  Type, length and amount of tobacco use was also documented.  The chart review 
assessed if providers documented their implementation of the first 3As of the 5A method 
from the tobacco use guideline recommendations.  All aspects of the note including chief 
complaint, history of present illness, social history, past medical history, assessment, and 
plan were examined for documentation of tobacco use and the first 3As of the 5A 
method.  For example, if tobacco use was listed under social or past medical history, the 
PI documented this as the patient being asked about tobacco use.   
 The second part of the study occurred after the chart review.  Primary care providers 
received written feedback and a brief educational intervention led by the principal 
investigator.  Written feedback was given to the providers at the educational intervention 
and included an overview of chart review methods as well as a summary of the findings. 
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Feedback was not individualized by provider.  The educational intervention lasted 
approximately sixty minutes and was conducted at the clinic during the providers' lunch 
hour in the clinic work room.  Lunch was offered to providers by the PI for their 
participation.   
 The educational session was attended by four primary care providers as well as the 
office manager and the PI's faculty advisor.  The session was led by the PI and briefly 
discussed the Tobacco Use and Dependence guideline, possible interventions that may 
increase compliance with the guideline, and resources available to patients and providers 
for treatment of tobacco use and dependence.  The educational intervention was designed 
using Knowles' adult learning principles (Knowles, 1996) and followed a focus group 
format in which discussion and open dialogue among the providers was encouraged.  
 Each provider received a binder that contained the quick reference guide of the 
Tobacco Use and Dependence guideline, provider and patient resources from the Ask and 
Act program from the American Association of Family Physicians (AAFP), and a 
pharmacologic guide to FDA-approved medications for smoking cessation.  The binder 
also contained information on documenting tobacco use and interventions in electronic 
health records as well as how to bill for tobacco use interventions and counseling.  Most 
of the sixty minute educational intervention was spent reviewing the guideline's quick 
reference guide and the remaining time was spent reviewing and discussing the other 
components in the binder.   
 Immediately after the educational intervention an anonymous survey was given to the 
providers who attended the educational intervention (Appendix C).  The survey assessed 
the providers' perception of the usefulness and effectiveness of the educational 
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intervention and performance feedback.  The six item survey used a five point Likert 
scale (1=strongly disagree with statement to 5=strongly agree with statement) to assess 
whether providers agreed or disagreed with statements pertaining to the educational 
intervention.  All data collected from the chart review and the provider survey were 
stored securely on the REDCap (Research Electronic Data Capture) account owned by 
the principal investigator and hosted at the University of Kentucky.  REDCap is a secure, 
web-based application that is utilized for building, managing, and storing online surveys 
and databases (Harris et al., 2009).   
Results 
 A total of 141 patient charts were selected for the retrospective chart review.  Of 
these fifteen charts were excluded because the patient was under 18 years old and 29 
charts were excluded because the patient was documented as a non-smoker.  Eighty-one 
charts (57%) did not have smoking status documented in the initial visit or current visit 
note.  Only sixteen charts were identified for further data collection.  Of these, two 
patients were documented as being ex-smokers but were included in the study because 
the Tobacco Use and Dependence guideline stresses the importance of intervening with 
current and former smokers (Figure 1). 
 The two patients documented as ex-smokers had an average age of 66 years old.  One 
of the patients was a female who had quit smoking nine years ago.  The other patient was 
a male who had quit smoking twenty years ago.  Both of these patients were asked about 
tobacco use during the current visit used for chart review.  Since a number of years had 
elapsed since these patients had quit using tobacco giving advice to quit and assessing 
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willingness to quit did not apply.  Therefore inclusion of these patients in the chart review 
was only added to rates of tobacco use documentation (ask). 
               
Figure 1: Chart Review Results
57%
21%
10% 1%
11%
Not documented n=81
Under 18 n=15
Non-smoker n=29
Smokers n=14
Ex-smokers n=2
   
 The average age of the fourteen documented current tobacco users was 50 years old 
and gender was evenly mixed (50% female, 50% male).  Race was documented as white 
(35.7%) or unknown (64.3%).  Race was obtained from the general clinic intake form and 
many patients did not provide racial or ethnic background information and therefore were 
documented as unknown.  Patients included in the chart review were all insured by 
various private and public insurances.  Chief complaints varied widely and included 
hypertension, depression and anxiety, sore throat and cough, dyspnea, itching, sexually 
transmitted disease check, ear infection, warts, yeast infection, insomnia, skin lesions, 
gynecological evaluation, and various complaints of pain.  
 Overall rates of documentation of the first 3As were poor.  The rate of asking about 
tobacco use was 56.2% (n=16, includes ex-smokers mentioned previously), rate of giving 
advice was 14.3% (n=14), and rate of documenting willingness to quit was 7.1% (n=14) 
total.  Six of the charts (42.9%) documented the type of tobacco used as cigarettes.  Three 
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charts (21.4%) specified amount of use which varied from "a little less than 1/2 pack per 
day" to three packs per day.  Only two charts (14.3%) had documentation of length of use 
(years and since teenager).    Table 3 provides a summary of the data obtained from the 
chart review.    
Table 3 Selected variables from retrospective chart review (N=14) 
Variable N Outcome 
Mean age in years 14 50  
Gender                        
     Male 
     Female 
 
7 
7 
 
50% 
50% 
Race 
     White 
     Unknown 
 
5 
9 
 
35.7% 
64.3% 
Documented type of tobacco use  6 42.9% 
Documented length of tobacco use 2 14.3% 
Documented amount of tobacco use 3 21.4% 
Rates of asking* 9 56.2% 
Rates of giving advice 2 14.3% 
Rates of assessing willingness to quit 1 7.1% 
  *n=16, includes two ex-smokers who were asked about tobacco use during current visit 
 Three family practice physicians and one family nurse practitioner participated in the 
educational intervention.  All providers who attended the intervention returned a provider 
survey.  Table 4 contains the survey responses that were obtained following the 
educational intervention.  Scores were highest for relevancy of the information presented 
in the session to the providers' practice (M=3.75).  Scores were lowest for increased 
motivation to intervene with tobacco users and the session's ability to make providers 
think about the way they practice (M=3.25).  There was a wide variation in the standard 
deviation as one provider rated the intervention poorly.   
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     Table 4 Provider survey responses (n=4) 
Variable Mean responsea SD Low High 
1. Information was relevant to 
practice 3.75 1.64 1 5 
2. Session motivated me to 
intervene with tobacco users 3.25 0.83 2 4 
3. Resources were useful 3.5 1.5 1 5 
4. I feel confident intervening 
with tobacco users 3.5 1.5 1 5 
5. Session expanded my 
knowledge 3.5 0.5 3 4 
6. Educational session made me 
think about the way I practice 3.25 1.48 1 5 
a Rating scale: 1=strongly disagree with statement to 5=strongly agree with statement 
Several subjective findings emerged from the educational intervention.  Providers 
stated support staff at the clinic were inadequately trained in tobacco use interventions.  
Support staff were not expected to ask about tobacco use when triaging or rooming the 
patient.  Providers also mentioned lack of time, lack of usability within the electronic 
health record (EHR), lack of resources, and patient indifference as barriers to 
implementing and documenting tobacco use interventions.   
Discussion 
Delivery of tobacco use interventions in primary care is essential to reducing tobacco-
related morbidity and mortality.  Primary care providers are in a key position to intervene 
with tobacco users.  Brief interventions with tobacco users are effective in increasing 
cessation attempts but are often not performed or documented (Fiore et al., 2008). 
The first step in intervening with tobacco users is to identify them.  This study 
demonstrated a poor identification rate of tobacco users.  Over 57% of charts reviewed 
did not have smoking status documented.  In 2009, the Health Information Technology 
for Economic and Clinical Health Act (HITECH) was established to provide incentives to 
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eligible providers for the adoption and use of EHR technology to capture health data, 
track clinical conditions, and coordinate care.  The criteria for obtaining incentives for 
tobacco use status is more than 50 percent of patients aged 13 and older have smoking 
status recorded (AAFP, n.d.).  Therefore this clinic is below the standards set by the 
HITECH act and would not qualify for incentives.   
One possible explanation for inadequate documentation of the tobacco use status is 
the lack of training and involvement by support staff.  Research has demonstrated that 
adding tobacco use status to vital sign attainment can improve tobacco use documentation 
(Milch, Edmunson, Beshansky, Griffith, & Selker, 2004; Piper et al., 2003; Rothemich et 
al., 2008; Szpunar, Williams, Dagroso, Engerg, & Chesney, 2006).  Obtaining tobacco 
use status as an additional vital sign was not routine practice at the study clinic.  Perhaps 
making this systems change would increase documentation of tobacco use status and thus 
improve overall implementation and documentation of tobacco use interventions.   
Similar to previous studies (Conroy et al., 2005a) this study found documentation of 
delivery of the first 3As of the 5A model to be poor in electronic health records.  
Electronic health records have the potential to increase adherence to clinical practice 
guidelines through decision support (Chaudhry et al., 2006).  Decision support usually 
includes computerized reminders that prompt clinicians to perform evidence-based 
interventions that pertain to their patients.  A recent Cochrane review (Boyle, Solberg, & 
Fiore, 2011) found only a modest improvement in documentation of smoking status and 
referral to cessation counseling following implementation of the expectation to utilize the 
EHR to record and treat tobacco use.  Future research should be directed at pinpointing 
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ways in which EHRs can be effectively utilized to increase adherence to clinical practice 
guidelines such as the tobacco use guideline.   
Providers in this study voiced concerns about the usability of their EHR to document 
tobacco use interventions.  The clinic was utilizing the "out of the box" or basic EHR 
software package from their selected EHR company.  This version did not include any 
tobacco-use related decision support such as prompts or reminders to provide tobacco use 
interventions.  Investing in a software upgrade that includes clinical decision support and 
computerized prompts may increase implementation of tobacco use and other preventive 
health care interventions at this clinic.   
Evidence has suggested that providing training and feedback to health care staff 
including physicians and nurse practitioners can improve implementation of tobacco use 
interventions (Andrews, Tingen, Waller, & Harper, 2001; Bentz et al., 2007; Carson et 
al., 2012).  Though mean scores of provider survey items were mediocre, most providers 
rated the educational session favorably.  Scores were highest for relevancy of information 
to the providers' practice which may indicate that the providers in this study view tobacco 
use interventions as an important aspect of primary care.  However scores for motivation 
and changing the way providers think about the way they practice were lowest.  Providers 
may feel lack of motivation to change practice due to systems barriers. 
In a recent synthesis of systematic reviews, Prior, Guerin, and Grimmer-Somers 
(2008) found that academic detailing and interactive education are superior strategies 
over passive dissemination and didactic education in improving clinical practice 
guideline implementation.  Though efforts were made during the educational session to 
obtain input and feedback from the providers perhaps the educational session should have 
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been designed with a more interactive approach such as incorporation of role playing 
exercises and case scenarios.    
Future interventions to increase provider compliance with tobacco use guidelines 
should promote provider input, involve support staff, and incorporate system changes that 
support tobacco use interventions.  Adoption of policies that outline the appropriate 
process and expectations for implementation of tobacco use interventions is critical in 
any primary care clinic.  For example, the policy should clarify what health care team 
member is responsible for documentation of smoking status and the correct method for 
documentation. 
Limitations 
A major limitation to this quality improvement study is the lack of follow-up.  An 
additional chart review following the educational session may have demonstrated 
improved documentation rates of tobacco use interventions.  Continued engagement and 
support may have aided the providers in implementing necessary systems changes that 
facilitate tobacco use interventions.  It is also difficult to discern the overall effect of the 
educational intervention since there was a small sample size and no pretest was 
administered.  If a survey or test had been administered prior to the educational 
intervention and then compared to the survey administered after the intervention it may 
have demonstrated some improvements in the provider's attitudes and perceptions 
pertaining to tobacco use interventions.   
Conclusion 
Clinical practice guidelines are valuable tools for clinicians to provide evidence-
based, safe, quality care.  The clinical practice guideline, Treating Tobacco Use and 
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Dependence (Fiore et al., 2008), recommends utilizing the 5As approach when 
intervening with tobacco users.  However this intervention is inadequately documented 
and implemented in primary care (Conroy et al., 2005a; Conroy et al., 2005b; Jamal et 
al., 2012; Quinn et al., 2005).  This study demonstrated poor documentation of tobacco 
use interventions in one primary care clinic.  The provider educational intervention in this 
study had mixed results but demonstrated overall favorable ratings for perceived provider 
knowledge, motivation, confidence, and attitudes as they relate to intervening with 
tobacco users.   
The lack of documentation of tobacco use interventions in the study clinic may be due 
to larger systems barriers such as EHR usability issues, support staff knowledge and 
skills, and lack of resources and time.  Primary care practices should individualize and 
adopt system changes that promote the adoption of tobacco use interventions.  
Specifically all primary care clinics should institute a chart labeling system that aids 
support staff and providers in the identification of tobacco users.  Charting systems, 
whether traditional paper method or electronic records, should be examined for usability 
issues and feature decision support systems such as reminders and prompts to intervene 
with tobacco users.  Education of staff and providers on guideline recommendations 
should be interactive and engaging.     
Future research should be directed at improving EHRs to streamline and facilitate the 
documentation and implementation of preventive health care, including tobacco 
cessation.  Research should also focus on specific educational and feedback components 
that improve adherence to tobacco use guidelines.  Continued efforts to implement 
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tobacco use interventions in primary care is an essential public health function that can 
greatly improve health outcomes. 
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Conclusion 
 
 The first manuscript details a critical analysis of the Public Health Service 
guideline on Treating Tobacco Use and Dependence.  The analysis demonstrated that the 
guideline is a valid, evidence-based resource for clinicians to use when intervening with 
tobacco users.  The guideline gives practical, specific recommendations that can be used 
by a variety of health care providers in a wide range of health care settings.  One of the 
major recommendations of the guideline is use of the 5As of smoking cessation.  Health 
care providers should ask their patients about tobacco use, assess their willingness to 
quit, advise them to quit, assist in their quit attempt, and arrange follow-up care.   
 Despite evidence that use of the 5As is effective in increasing smoking cessation 
rates it is often underutilized by health care providers (Fiore et al., 2008).  The second 
manuscript discusses interventions that increase provider compliance with guideline 
recommendations, specifically using the 5A method.  The literature review revealed that 
multi-component interventions are most effective in increasing utilization of the 5A 
method.  Use of a vital sign stamp or computerized prompt and provision of provider 
education and feedback appear to be effective interventions in improving rates of 5A 
delivery in the primary care setting.   
 The third manuscript details a descriptive study of the documentation and 
implementation of tobacco use interventions in a primary care setting.  The study 
demonstrated that documentation rates of tobacco use interventions, specifically the first 
three of the 5As, were poor.  An educational intervention that provided written feedback 
to providers did not demonstrate a clear benefit in the confidence, motivation, or 
knowledge of the providers as it relates to intervening with tobacco users.  However, the 
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intervention did reveal some potential systems issues that may have contributed to the 
poor documentation and implementation of tobacco use interventions at the clinic.  
Providers cited lack of resources and time, poor design of the electronic health record, 
and inadequate training of support staff as barriers to implementation of tobacco use 
resources.   
 The first key step in assisting tobacco users with cessation is to identify them at 
every health care visit.  Evidence has demonstrated that adding tobacco use status to vital 
signs has greatly improved the recognition of and subsequent intervention with tobacco 
users.  Primary care clinics, such as the clinic in which the study was conducted, that do 
not have policies and procedures in place to identify tobacco users should implement this 
important step.   
 Electronic health records can aid primary care clinicians in providing preventive 
health care, including tobacco cessation, by providing prompts and utilizing clinical 
decision support systems.  Primary care providers should encourage administrators and 
information technology staff to purchase, install, and update electronic health record 
programs that incorporate user-friendly decision support systems.  Adequate training and 
support should be given to providers on proper use of the electronic health record.  
Policies should be enacted that clearly detail documentation expectations of all health 
care staff.   
 The 5As method of smoking cessation is a brief, evidence-based intervention that 
can be easily utilized by primary care providers.  By providing education and feedback 
and promoting a clinic environment in which implementing tobacco use interventions is 
encouraged and facilitated, primary care providers can successfully help their patients 
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quit.  Smokers typically make multiple quit attempts prior to successfully quitting.  
Therefore it is essential that health care providers identify tobacco users and provide 
evidence-based interventions that promote cessation.  By utilizing clinical practice 
guidelines and recognizing important systems issues within a clinic, primary care 
providers can make a significant impact in their patient population of tobacco users.        
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Appendix A 
Brief Summary of Guideline Recommendations 
 
Clinical Interventions 
 Every health care provider should identify and intervene with tobacco users using 
the first 3 of the 5As (ask about tobacco use, assess willingness to quit, and advise all 
users to quit).  Asking about tobacco use should be done in a systematic way, such as 
with vital signs, to ensure that every patient at every visit has tobacco use status assessed 
and documented (Fiore et al., 2008).  Screening for tobacco use will result in one of four 
scenarios:  
 1. A current tobacco user unwilling to quit 
 2. A current tobacco user willing to quit   
 3. A former tobacco user  
 4. An individual that has never regularly used tobacco 
 For individuals that have never regularly used tobacco products or who have quit 
using tobacco products, continued abstinence should be encouraged.  For current users, 
the clinician should advise the patient to quit in a clear, personalized, and strong manner 
(Fiore et al., 2008).  If the patient is willing to quit the clinician should assist the 
individual in his or her quit attempt by helping the patient develop a quit plan, 
recommend the use of approved medications, and provide practical counseling, 
intratreatment social support, and supplementary materials.  The clinician should arrange 
for frequent follow up during the patient's quit attempt (Fiore et al., 2008).   
 All smokers trying to quit should be offered approved medication unless 
contraindicated or for populations in which insufficient evidence exists for the 
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effectiveness of the medication (e.g. pregnant women, adolescents, light smokers).   
Approved medications include bupropion SR, nicotine gum, nicotine lozenge, nicotine 
nasal spray, nicotine patch, and varenicline (Fiore et al., 2008).  The guideline provides 
information about the clinical use of each of these medications.  
 Counseling is an effective treatment method for smoking cessation, both alone 
and in combination with pharmacologic treatment.  All clinicians can provide basic 
practical counseling by helping the patient to recognize triggers or danger situations and 
to develop coping skills (Fiore et al., 2008).  Danger situations may include stress, 
alcohol, or being around others that use tobacco.  Coping skills may include lifestyle 
changes that reduce stress or cognitive strategies that improve mood (Fiore et al., 2008).  
Providers can also provide social support through encouragement and caring, giving 
supplemental information such as quit-line brochures, and discussing basic information 
about quitting. 
 For current tobacco users that are unwilling to make a quit attempt, clinicians 
should use motivational interventions based on the principles of motivational 
interviewing (MI) to move the patient closer to making a quit attempt.  The general 
principles of MI are express empathy, develop discrepancy, roll with resistance, and 
support self-efficacy (Fiore et al, 2008).  The guideline gives examples of using each of 
these principles to motivate tobacco users towards a quit attempt.  The guideline also 
discusses the 5R's to enhance motivation to quit.  The 5R's are relevance, risks, rewards, 
roadblocks, and repetition.  Providers should encourage patients to discuss why quitting 
smoking or tobacco products is personally relevant to them.  Providers should aid patients 
in identifying negative consequences of tobacco use (risks), potential benefits of quitting 
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(rewards), and possible barriers to quitting (roadblocks).  These motivational 
interventions should be repeated at every clinic visit at which the patient expresses no 
interest in making a quit attempt (Fiore et al., 2008).   
 For smokers or tobacco users who have recently quit providers should 
congratulate the patient and use open-ended questions to explore topics relevant to 
quitting tobacco.  Topics that can be discussed include the benefits of quitting, success 
the patient has had in quitting, barriers to continued abstinence, and medication related 
information.  All patients that have recently quit should receive follow up care for 
continued assistance and support (Fiore et al., 2008). 
 The guideline also recommends more intensive interventions by specially trained 
clinicians in the treatment of tobacco use and dependence.  State tobacco quit lines (1-
800-QUIT-NOW) provide intensive specialist-delivered interventions and can be utilized 
easily by all tobacco users (Fiore et al., 2008).  The guideline discusses in detail 
components of intensive interventions and how specialists may contribute to tobacco 
control efforts.   
System interventions 
 Health care administrators, purchasers, and insurers should ensure that 
institutional changes are made that promote tobacco use dependence interventions and 
treatments systematically and universally.  Strategies that might facilitate these 
interventions include implementation of a tobacco user identification system in every 
clinic, provision of adequate training and resources to staff, dedicating staff to provide 
tobacco dependence treatment, promoting hospital policies that support and provide 
tobacco dependence services, and including all effective treatments (counseling and 
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medications) as covered or paid services for all members of health insurance packages 
(Fiore et al., 2008). 
 Expanding the vital signs to include tobacco use status is the recommended 
approach to ensure universal, system-wide identification of tobacco users.  All healthcare 
providers should be given education, resources, and feedback that promote the provision 
of tobacco use dependence interventions and treatment (Fiore et al., 2008).  All clinics 
should designate a tobacco dependence treatment coordinator and communicate to other 
staff their responsibilities in the delivery of tobacco dependence services.  All hospitals 
should have policies in place that ensure every tobacco user admitted to the hospital is 
offered tobacco dependence treatment.  Evidence-based tobacco use treatments, including 
medication and counseling, should be included as part of the basic benefits package for 
all health insurances without barriers such as co-pays or prior authorizations (Fiore et al., 
2008).   
Conclusion 
 Overall the guideline stresses that tobacco use is a chronic disease that requires 
multiple interventions and attempts to quit.  Therefore it is essential that every health care 
provider assess tobacco use status and use evidence-based tobacco dependence treatment 
to assist users in their quit attempts.  Tobacco dependence treatments are clinically 
effective and cost-effective and should be supported and promoted by health care 
providers as well as insurers, purchasers, and health care administrators.   
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Appendix B  
Data Collection Form 
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Appendix C 
Provider Survey 
 
This survey pertains to an educational session you attended on the Tobacco Use and 
Dependence Guidelines.  Please respond to the following items to the best of your ability.  
 
 
1. The information presented in the session was relevant to my practice 
 
1  2  3  4  5 
Strongly Disagree      Strongly Agree 
 
 
2. The educational session motivated me to intervene with tobacco users I see in clinic 
 
1  2  3  4  5 
Strongly Disagree      Strongly Agree 
 
 
3. Resources (pamphlets, websites, etc.) given during the educational session were useful. 
 
1  2  3  4  5 
Strongly Disagree      Strongly Agree 
 
 
4.  After the educational session, I feel confident intervening with tobacco users. 
 
1  2  3  4  5 
Strongly Disagree      Strongly Agree 
 
 
5.  The educational session expanded my knowledge on evidence-based ways to help my 
patients overcome tobacco addiction. 
 
1  2  3  4  5 
Strongly Disagree      Strongly Agree 
 
 
6.  The educational session made me think about the way I practice. 
 
1  2  3  4  5 
Strongly Disagree      Strongly Agree 
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